Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5056 to 5070 of 8221 results

  1. Increasing the dose of ICS within a personalised self-management programme for children and young people - For children and young people with asthma that is managed in primary care, is there an advantage to increasing the inhaled corticosteroid (ICS) dose when asthma control has deteriorated compared with using the usual dose in a self-management programme?

    Recommendation ID NG80/11 Question Increasing the dose of ICS within a personalised self-management programme for children and young people

    Research recommendation
    Published
    6 August 2021

  2. Renin–angiotensin–aldosterone system antagonists: For people aged over 75 years with CKD, what is the clinical effectiveness of renin–angiotensin–aldosterone system (RAAS) antagonists? [2014]

    Recommendation ID NG203/20 Question Renin–angiotensin–aldosterone system antagonists: For people aged over 75 years with CKD, what is the

    Research recommendation
    Published
    30 September 2021

  3. Multicomponent intervention: For people in long-term care, is a multicomponent non-pharmacological intervention more clinically and cost effective than usual care in preventing the development of delirium?

    Recommendation ID CG103/04 Question Multicomponent intervention: For people in long-term care, is a multicomponent non-pharmacological

    Research recommendation
    Published
    3 February 2023

  4. Starting asthma treatment:- In adults, young people and children with asthma who have not been treated previously, is it more clinically and cost effective to start treatment with a reliever alone (a short-acting beta2 agonist [SABA]) or with a reliever (a SABA) and maintenance therapy (such as ICS)? Are there specificprognostic features that indicate that one of these treatment options may be more appropriate for some groups?

    Recommendation ID NG80/6 Question Starting asthma treatment:- In adults, young people and children with asthma who have not been treated

    Research recommendation
    Published
    18 October 2018

  5. Social media:- How effective are online social media and networks at improving health and wellbeing and reducing health inequalities when they are used:- as a method of community engagement?- to support an existing community engagement approach?

    Recommendation ID NG44/4 Question Social media:- How effective are online social media and networks at improving health and wellbeing and

    Research recommendation
    Published
    7 April 2016

  6. What is the effectivness of statin treatment in older people?

    Recommendation ID NG238//2 Question What is the effectivness of statin treatment in older people? Any explanatory notes(if applicable)

    Research recommendation
    Published
    3 May 2024

  7. The committee noted that there was no clinical evidence showing that having sodium zirconium cyclosilicate improved length or quality of life or allowed patients to stay on optimal doses of renin-angiotensin-aldosterone system (RAAS) inhibitors. It therefore considered that it would be valuable to have studies comparing sodium zirconium cyclosilicate plus standard care with standard care alone in people with confirmed hyperkalaemia of 6.0 mmol/litre and above, and that these should investigate: mortality disease progression patterns of RAAS inhibitor use healthcare utilisation, and health-related quality of life.

    Recommendation ID TA599/1 Question The committee noted that there was no clinical evidence showing that having sodium zirconium cyclosilicate

    Research recommendation
    Published
    8 November 2019

  8. What is the clinical and cost effectiveness of cannabis-based medicinal products other than THC: CBD spray for children, young people and adults with spasticity? In particular, what is the impact of spasticity on improvements in quality of life?

    Recommendation ID NG144/5 Question What is the clinical and cost effectiveness of cannabis-based medicinal products other than THC: CBD

    Research recommendation
    Published
    10 February 2020

  9. Stereotactic ablative radiotherapy compared with surgery: What is the effectiveness and cost effectiveness of stereotactic ablative radiotherapy (SABR) compared with surgery (for example, sublobar, wedge resection, lobectomy) for people with non-small-cell lung cancer (stage I and IIA) in whom surgery is suitable?

    Recommendation ID NG122/2 Question Stereotactic ablative radiotherapy compared with surgery: What is the effectiveness and cost effectiveness

    Research recommendation
    Published
    27 April 2023

  10. Stopping antiviral treatment in HBeAg-negative disease:- Further research should be undertaken to evaluate the clinical and cost effectiveness of hepatitis B surface antigen (HBsAg) quantitative assays in determining treatment duration in hepatitis B e antigen- (HBeAg) negative disease.

    Recommendation ID CG165/1 Question Stopping antiviral treatment in HBeAg-negative disease:- Further research should be undertaken to evaluate

    Research recommendation
    Published
    9 June 2015

  11. Specialist dementia support:- What is the most effective and cost effective way to support people with dementia living at home?

    Recommendation ID NG21/4 Question Specialist dementia support:- What is the most effective and cost effective way to support people with

    Research recommendation
    Published
    13 October 2015

  12. Switching from inpatient intravenous to outpatient oral antibiotic therapy in patients with neutropenic sepsis:- A randomised controlled trial should be undertaken to evaluate the clinical and cost effectiveness of stopping intravenous antibiotic therapy and switching to oral therapy within the first 24 hours of treatment in patients with neutropenic sepsis who are having treatment with intravenous antibiotics. The outcomes to be measured are overtreatment, death, need for critical care, length of hospital stay, duration of fever and quality of life.

    Recommendation ID CG151/5 Question Switching from inpatient intravenous to outpatient oral antibiotic therapy in patients with neutropenic

    Research recommendation
    Published
    9 June 2015

  13. Stopping preventive medicines:- What is the clinical and cost effectiveness of stopping preventive medicines in people with multimorbidity who may not benefit from continuing them?

    Recommendation ID NG56/3 Question Stopping preventive medicines:- What is the clinical and cost effectiveness of stopping preventive medicines

    Research recommendation
    Published
    18 October 2016

  14. Specialist investigation:- What specialist investigations should be conducted to exclude a diagnosis of functional dyspepsia in people with uninvestigated dyspepsia that does not respond to PPIs or H2 receptor antagonists (H2RAs) despite optimum primary care?

    Recommendation ID CG184/5 Question Specialist investigation:- What specialist investigations should be conducted to exclude a diagnosis

    Research recommendation
    Published
    9 June 2015

  15. Which patients, other than those known to have a high risk of complications or mortality, would benefit from postoperative care in a specialist recovery area (a high-dependency unit, a post-anaesthesia care unit or an intensive care unit)?

    Recommendation ID NG180/5 Question Which patients, other than those known to have a high risk of complications or mortality, would benefit

    Research recommendation
    Published
    26 October 2020